(Q35114576)

6 August 2017

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer (English)

1 reference

6 August 2017

1 reference

1 reference

52

1 reference

6 August 2017

Georgia Chenevix-Trench

56

Australian Ovarian Cancer Study Group

Georgia Chenevix-Trench

0 references

62

Australian Ovarian Cancer Study Group

1 reference

6 August 2017

36

Angela Chetrit

0 references

Kathryn Alsop

Kathryn Alsop

7

0 references

Kelly Bolton

Kelly L Bolton

14

0 references

Maria Jose Garcia

Maria J Garcia

24

0 references

Allan Jensen

Allan Jensen

39

0 references

David Bowtell

David Bowtell

58

0 references

Estrid Høgdall

Estrid Høgdall

40

0 references

Ignacio Blanco

Ignacio Blanco

28

0 references

Susan J. Ramus

Susan J Ramus

10

0 references

Susanne Krüger Kjaer

Susanne K Kjaer

38

0 references

Anna Marie Mulligan

Anna Marie Mulligan

26

0 references

Håkan Olsson

Håkan Olsson

21

0 references

Paul D P Pharoah

59

Paul D P Pharoah

1 reference

6 August 2017

35

Siegal Sadetzki

1 reference

6 August 2017

49

Diether Lambrechts

1 reference

6 August 2017

41

Susan Neuhausen

1 reference

6 August 2017

54

Douglas F Easton

1 reference

6 August 2017

51

Debra Frost

1 reference

6 August 2017

25

Irene Andrulis

1 reference

6 August 2017

48

Amanda E Toland

1 reference

6 August 2017

kConFab Investigators

61

kConFab Investigators

1 reference

6 August 2017

29

Conxi Lazaro

1 reference

6 August 2017

27

Gord Glendon

1 reference

6 August 2017

4

Julie M Cunningham

1 reference

6 August 2017

55

Antonis Antoniou

1 reference

6 August 2017

0 references

30

Alice S Whittemore

1 reference

6 August 2017

47

Kirsten Moysich

1 reference

6 August 2017

57

Simon A Gayther

1 reference

6 August 2017

5

Brooke L Fridley

1 reference

6 August 2017

3

Ellen L Goode

1 reference

6 August 2017

43

Mary Daly

1 reference

6 August 2017

32

Weiva Sieh

1 reference

6 August 2017

9

Patricia Harrington

1 reference

6 August 2017

17

Beth Karlan

1 reference

6 August 2017

31

Valerie McGuire

1 reference

6 August 2017

2

Honglin Song

1 reference

6 August 2017

22

Martin Gore

1 reference

6 August 2017

11

Anna de Fazio

1 reference

6 August 2017

33

Marco Montagna

1 reference

6 August 2017

13

Sian Fereday

1 reference

6 August 2017

37

Ava Kwong

1 reference

6 August 2017

44

Mark H Greene

1 reference

6 August 2017

15

Charlie Gourley

1 reference

6 August 2017

20

Ilana Cass

1 reference

Francisco Jose Candido Dos Reis

6 August 2017

1

Francisco J Candido-dos-Reis

1 reference

6 August 2017

34

Elisa Alducci

1 reference

6 August 2017

53

Marc Tischkowitz

1 reference

6 August 2017

18

Jenny Lester

1 reference

6 August 2017

19

Christine Walsh

1 reference

6 August 2017

Melissa C Larson

6

1 reference

6 August 2017

Ed Dicks

8

1 reference

6 August 2017

Gillian Mitchell

12

1 reference

6 August 2017

Caroline Michie

16

1 reference

6 August 2017

Javier J Benitez

23

1 reference

6 August 2017

Robert Nussbaum

42

1 reference

6 August 2017

Phuong L Mai

45

1 reference

6 August 2017

Jennifer T Loud

46

1 reference

6 August 2017

Steve Ellis

50

1 reference

6 August 2017

for EMBRACE

60

1 reference

6 August 2017

language of work or name

English

0 references

publication date

14 November 2014

1 reference

6 August 2017

Clinical Cancer Research

1 reference

6 August 2017

21

1 reference

6 August 2017

3

1 reference

6 August 2017

652-657

1 reference

Diet quality and survival after ovarian cancer: results from the Women's Health Initiative

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Integrated genomic analyses of ovarian carcinoma

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Multiple imputation using chained equations: Issues and guidance for practice

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

The impact of heterogeneity on the comparison of survival times.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

11 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Improved survival in women with BRCA-associated ovarian carcinoma

11 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4338615

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

11 August 2018

1 reference

12 December 2020

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

12 December 2020

The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin

1 reference

12 December 2020

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

12 December 2020

BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo

1 reference

12 December 2020

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer

1 reference

12 December 2020

10.1158/1078-0432.CCR-14-2497

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference